ArticleScientific reports2022
Impact of COVID-19 on cancer screening in South Korea.
Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Prevalence of Cervical Cancer Screening in Asia: A Systematic Review and Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2025Pooled it
- Prevalence of Breast Cancer Screening in Asia: Systematic Review and Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2024Pooled it
- The Impact of the COVID-19 Pandemic on Breast and Cervical Cancer Screening: A Systematic Review.In vivo (Athens, Greece)Pooled it
- Article
- Absolute and relative socioeconomic inequalities in cancer screening participation among adults aged 40-74 years in South Korea: a repeated cross-sectional study.BMC public health · 2026Article
- Changes in the monitoring and management of hypertension during the COVID-19 pandemic.BMC public health · 2025Article
- Determinants of Prostate Cancer Screening in Korean Men: A Nationwide Study Using the Korean National Cancer Screening Survey 2023.Cancer research and treatment · 2025Article
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2022.Cancer research and treatment · 2025Article
- The impact of the COVID-19 Pandemic on breast cancer incidence and stage: Results of a retrospective study.Qatar medical journal · 2025Article
- Article
- Association between Endoscopist Volume and Interval Cancers after Colonoscopy: Results from the National Colorectal Cancer Screening Program in Korea.Cancer research and treatment · 2024Article
- Resilience Gap in Gastrointestinal Endoscopy Activity during the COVID-19 Pandemic in South Korea.Chonnam medical journal · 2024Article
- Towards AI-Driven Healthcare: Systematic Optimization, Linguistic Analysis, and Clinicians' Evaluation of Large Language Models for Smoking Cessation Interventions.Proceedings of the SIGCHI conference on human factors in computing systems. CHI Conference · 2024Article
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2021.Cancer research and treatment · 2024Article
- Impact of Coronavirus Disease 2019 on the Diagnosis and Treatment of Pancreatic Cancer: An Observational Cohort Study.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024Observational
- Impact of coronavirus disease 2019 on cancer care: How the pandemic has changed cancer utilization and expenditures.PloS one · 2024Article
- COVID-19 pandemic impact on the potential exacerbation of screening mammography disparities: A population-based study in Ontario, Canada.Preventive medicine reports · 2024Article
- Changes in the Percentage of Patients Treated for Cancer Before and After the SARS-CoV-2 Epidemic: A Retrospective Observational Study.Juntendo Iji zasshi = Juntendo medical journal · 2024Article
- Excess mortality during the Coronavirus disease pandemic in Korea.BMC public health · 2023Article
- Maintaining early diagnosis of pancreatic adenocarcinoma in Japan: Local resilience against COVID-19.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease (COVID-19) pandemic significantly declined cancer screening rates worldwide. Its impact on the South Korean population is unclear, depending on socioeconomic status (SES), residence, and history of chronic disease. This study utilized data (2018-2020) from the Korean National Cancer Screening Survey, an annual cross-sectional study employing nationally representative random sampling. Cancer screening rates were defined as the proportion of the eligible population who received respective cancer screening within the last 1 year and investigated four major cancers (stomach, colorectal, breast, and cervical). Screening rates every year were compared with screening rate ratios (SRRs) and the corresponding 95% confidence intervals (CIs). Between 2019 and 2020, screening rates declined significantly by 23%, 17%, 12%, and 8% for colorectal cancer (SRR 0.77; 95% CI 0.73-0.82), stomach cancer (SRR 0.83; 95% CI 0.79-0.87), breast cancer (SRR 0.88; 95% CI 0.82-0.93), and cervical cancer (SRR 0.92; 95% CI 0.87-0.97), respectively. Regardless of cancer type, screening was significantly lower in metropolitan residents, those with higher SES, and, interestingly, those without a history of chronic diseases. The significant decline in cancer screening during the pandemic requires urgent political intervention to reduce the burden of future cancer incidence and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.